Ligand Pharmaceuticals | LGND - PE Price to Earnings


Ligand Pharmaceuticals reported 60.65 in PE Price to Earnings for its fiscal quarter ending in September of 2025.





Pe Change Date
Amgen 25.31 15.82 Dec/2025
Anika Therapeutics 47.54 27.2 Jun/2024
Baxter International 17.1 4.46 Sep/2025
Bristol-Myers Squibb 9.28 1.04 Dec/2025
Eli Lilly 40.21 9.66 Dec/2025
Enviri Corporation 121.21 92.59 Jun/2023
Gilead Sciences 15.63 0.08 Dec/2025
GlaxoSmithKline 11.15 0.29 Dec/2025
Glaxosmithkline 11.66 0.28 Dec/2025
Intrexon 7.54 221.44 Dec/2021
Ionis Pharmaceuticals 396.15 79.28 Sep/2022
Ligand Pharmaceuticals 60.65 17.62 Sep/2025
Merck 13.92 5.08 Dec/2025
Pacira 52.68 23.44 Dec/2025
Pfizer 14.48 5.18 Dec/2025
Rigel Pharmaceuticals 8.61 8.4 Mar/2025
Veracyte 45.3 5.4 Dec/2025